HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway — Las Vegas, Nevada

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway is a clinical research site located in Las Vegas, Nevada, United States 89109.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway has participated in 136 clinical trials with 78 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway?

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway conducted?

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway has 136 clinical trials on record, with 78 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Is HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway accredited by Crixeo Health?

HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.